Is Unihealth Hospitals the Best Stock in Its Sector? A Look at the Numbers
- October 19, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Unihealth Hospitals CMP Rs 540 (19 Oct 2026). Market cap Rs 859 Cr. ROE 18.77%. P/E 18.77x versus Industry P/E 60.47x.
Quick Answer
Unihealth Hospitals is one of the names investors compare when screening the Healthcare Services sector. Whether it is the best stock in its sector depends on whether an investor prioritises return ratios, valuation or balance sheet strength. This article sets it against two named peers and the sector benchmark so you can judge for yourself.
Is Unihealth Hospitals the best stock in its sector? The stock trades on the NSE at Rs 540 as of 19 October 2026, within its 52-week range of Rs 153.55 to Rs 820.00. The sections below cover the business, the key ratios, a peer comparison and a closer look at valuation.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Unihealth Hospitals
Unihealth Hospitals Ltd, also referred to as Unihealth Consultancy Ltd in some data sources, is headquartered in Mumbai and was incorporated in 2010. It operates under the UMC Hospitals brand with a global presence, particularly in Africa. Its services include hospital and medical centre services, healthcare consultancy and project management, export and distribution of pharmaceutical and medical consumables, and medical value travel facilitation for international patients. At a market capitalisation of Rs 859 Cr, it is tracked as part of the Healthcare Services sector on Univest.
Is Unihealth Hospitals the Best Stock in Its Sector?
Unihealth Hospitals makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, backed by its return on equity. Unihealth Hospitals’ 18.77x P/E is below the 60.47x Industry P/E, Narayana Hrudayalaya at 42.28x and Rainbow Children’s Medicare at 43.38x, while its 18.77% ROE is higher than Narayana Hrudayalaya at 17.76% and Rainbow Children’s Medicare at 16.89%, and its debt to equity ratio of 0.27 is below Narayana Hrudayalaya at 1.29 and Rainbow Children’s Medicare at 0.54.
| Metric | Unihealth Hospitals |
|---|---|
| CMP (NSE) | Rs 539.95 |
| 52-Week High / Low | Rs 820.00 / Rs 153.55 |
| Market Cap | Rs 859 Cr |
| P/E (TTM) vs Industry P/E | 18.77x vs 60.47x |
| P/B | 6.17 |
| ROE | 18.77% |
| EPS (TTM) | Rs 28.76 |
| Dividend Yield | 0.00% |
| Debt to Equity | 0.27 |
Compare Unihealth Hospitals Against Other Healthcare Services Sector Stocks
How Unihealth Hospitals Compares Against Its Healthcare Services Sector Peers
The table below sets Unihealth Hospitals against 2 other Healthcare Services sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Unihealth Hospitals | 859 | 18.77 | 18.77% | 0.27 |
| Narayana Hrudayalaya | 34,527 | 42.28 | 17.76% | 1.29 |
| Rainbow Children’s Medicare | 12,593 | 43.38 | 16.89% | 0.54 |
| Peer average (2 companies) | – | 42.83 | 17.33% | 0.92 |
Measured against the peer averages, Unihealth Hospitals’ P/E is 56 percent below the 42.83x average, and its ROE is 1.44 percentage points above the 17.33% average. An average of just two companies is a rough guide, so treat the gap as a pointer for further research and not as a verdict.
What Makes Unihealth Hospitals Worth Watching in Healthcare Services
- Scale: At Rs 859 Cr, its market capitalisation is smaller than Narayana Hrudayalaya (Rs 34,527 Cr) and Rainbow Children’s Medicare (Rs 12,593 Cr), which is a useful reminder that the peers differ in size as well as in valuation.
- Sector drivers: Patient volumes at its overseas facilities, consultancy and project management contracts and exports of medical consumables drive its revenue.
- Key risk: A large part of its presence is overseas, particularly in Africa, so currency movements and local regulation matter, and the share price is far above its 52-week low, which leaves less room for disappointment.
Unihealth Hospitals Valuation: Is It Justified?
At a P/B ratio of 6.17, the market pays about Rs 6.17 for every rupee of book value, and the EPS (TTM) of Rs 28.76 is the earnings base behind the P/E. The stock trades about 34 percent below its 52-week high and about 3.5 times its 52-week low. The company does not currently show a dividend yield, so returns for shareholders depend mainly on the share price. As with any single stock, investors should weigh these figures against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Oracle Financial Services Software the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Unihealth Hospitals and other Healthcare Services sector stocks.
How to Track Unihealth Hospitals Before You Invest
Before deciding whether Unihealth Hospitals deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare Services sector peers using the steps below.
- Open the Univest Screener and search for Unihealth Hospitals to view live price, valuation ratios, and peer comparisons within the Healthcare Services sector.
- Compare its P/E, P/B, and ROE against other Healthcare Services sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Unihealth Hospitals gives investors a clear set of numbers to work with, from returns and valuation to leverage and peer standing. Whether it earns the label of best stock in Healthcare Services depends on how much weight you give each of them and on how the business executes from here. Because the stock trades below its sector benchmark, the open question is whether earnings growth will close that gap or whether the discount is deserved. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Unihealth Hospitals the best stock in its sector?
Ans. There is no single definitive answer, because the best stock in a sector depends on whether an investor is prioritising returns, valuation or balance sheet strength. Unihealth Hospitals has an 18.77% ROE and trades at 18.77x P/E against a 60.47x Industry P/E. Against the 2 peers compared in this article, its ROE is above the 17.33% peer average and its P/E is below the 42.83x peer average. Its debt to equity ratio of 0.27 is below the 0.92 peer average, which matters because borrowing can inflate returns and add risk when business conditions weaken. These figures are best read together rather than in isolation, and they work as a starting point for your own research and not as a verdict.
What is the current share price of Unihealth Hospitals?
Ans. Unihealth Hospitals was trading at Rs 539.95 on the NSE as of 19 October 2026, and its 52-week range runs from Rs 153.55 to Rs 820.00. That leaves the share price 34 percent short of the 52-week high and 3.5 times the 52-week low. Its market capitalisation is Rs 859 Cr and its EPS (TTM) is Rs 28.76, which is the earnings figure behind the 18.77x P/E. Share prices change through the trading day, so check the live quote on Univest before acting on any number here.
What sector does Unihealth Hospitals belong to?
Ans. Unihealth Hospitals is classified under the Healthcare Services sector on Univest, and that group of listed companies is the reference point for the 60.47x Industry P/E used in this article. The 2 named peers compared here are Narayana Hrudayalaya and Rainbow Children’s Medicare, chosen as comparable listed names so that the P/E, ROE and debt figures come from the same live data source. Investors who want a wider view can compare more Healthcare Services sector stocks on the Univest Screener, since no two companies in a sector have exactly the same business mix.
How does Unihealth Hospitals compare to its sector peers on P/E?
Ans. Unihealth Hospitals’ P/E of 18.77x is below the 42.83x average of the 2 named peers, with Narayana Hrudayalaya at 42.28x and Rainbow Children’s Medicare at 43.38x. It also sits below the 60.47x Industry P/E, which is the benchmark for the wider Healthcare Services sector. A P/E that is below a peer average can reflect a valuation discount or premium, but it can also reflect different growth or return expectations, so it should be read alongside ROE and debt. Its P/B ratio of 6.17 gives one more view of how the market values its book value.
What is Unihealth Hospitals’ return on equity?
Ans. Unihealth Hospitals reported a return on equity of 18.77%, which is above the 17.33% average of its named peers, with Narayana Hrudayalaya at 17.76% and Rainbow Children’s Medicare at 16.89%. ROE shows how much profit a company generates on every rupee of shareholders’ equity, so a higher figure generally points to more efficient use of capital. ROE is easier to trust when leverage is modest, and here the debt to equity ratio is 0.27 against a peer average of 0.92. It is worth checking whether the ROE has been stable over several years rather than relying on a single reading.
Should I invest in Unihealth Hospitals based on its sector position?
Ans. Sector position is only one input into an investment decision. Unihealth Hospitals has an 18.77% ROE and a 18.77x P/E, which make it worth researching further, and its dividend yield is 0.00%. You should also weigh its business outlook, earnings consistency, debt levels, your investment horizon and your own risk appetite before buying. Spreading money across several stocks and sectors reduces concentration risk, and this article is educational content, not investment advice. For personalised guidance, consult a SEBI-registered advisor.
